Triple-negative breast cancers express receptors for luteinizing hormone-releasing hormone (LHRH) and respond to LHRH antagonist cetrorelix with growth inhibition - Buchholz, S; Seitz, S; Schally, A V (Int J Oncol, 2009)
et al.